Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,228 | -93,092 | -129,855 | -62,152 | -97,634 |
| Depreciation Amortization | -1,135 | 653 | 42,690 | 678 | -1,241 |
| Income taxes - deferred | N/A | N/A | -2,531 | 0 | -774 |
| Accounts receivable | 901 | -608 | 894 | 2,144 | -944 |
| Other Working Capital | 76,341 | -2,122 | -11,401 | -30,309 | -9,527 |
| Other Operating Activity | 7,864 | 10,706 | 6,807 | 26,682 | 26,053 |
| Operating Cash Flow | $22,743 | $-84,463 | $-93,396 | $-62,957 | $-84,067 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -231 | -102 | -2,239 | -470 | -1,554 |
| Purchase Of Investment | -133,922 | -27,583 | -160,446 | -193,188 | -281,334 |
| Sale Of Investment | 65,015 | 116,825 | 187,700 | 263,478 | 232,570 |
| Other Investing Activity | 0 | 1,500 | 1,500 | -1,750 | 0 |
| Investing Cash Flow | $-69,138 | $90,640 | $26,515 | $68,070 | $-50,318 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,818 | 614 | 53,064 | 7,599 | 135,408 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 4,238 |
| Financing Cash Flow | $13,818 | $614 | $53,064 | $7,599 | $139,646 |
| Beginning Cash Position | 52,418 | 45,627 | 59,444 | 46,732 | 41,471 |
| End Cash Position | 19,841 | 52,418 | 45,627 | 59,444 | 46,732 |
| Net Cash Flow | $-32,577 | $6,791 | $-13,817 | $12,712 | $5,261 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,743 | -84,463 | -93,396 | -62,957 | -84,067 |
| Capital Expenditure | -255 | -102 | -3,096 | -470 | -1,554 |
| Free Cash Flow | 22,488 | -84,565 | -96,492 | -63,427 | -85,621 |